We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$191M
AUM Growth
-$14.6M
(-7.1%)
Cap. Flow
-$345M
Cap. Flow
% of AUM
-180.13%
Top 10 Holdings %
Top 10 Hldgs %
63.72%
Holding
82
New
18
Increased
24
Reduced
10
Closed
23
Top Buys
| 1 |
PRA Group
PRAA
|
+$8.14M |
| 2 |
SWFT
Swift Transportation Company
SWFT
|
+$5.03M |
| 3 |
Biogen
BIIB
|
+$4.05M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$3.99M |
| 5 |
Cardinal Health
CAH
|
+$3.82M |
Top Sells
| 1 |
RRTS
RoadRunner Transportation Systems, Inc.
RRTS
|
+$8.4M |
| 2 |
FedEx
FDX
|
+$7.22M |
| 3 |
MidCap Financial Investment
MFIC
|
+$5.34M |
| 4 |
Apollo Global Management
APO
|
+$4.43M |
| 5 |
Brookdale Senior Living
BKD
|
+$4.02M |
Sector Composition
| 1 | Healthcare | 66% |
| 2 | Financials | 8.92% |
| 3 | Communication Services | 6.09% |
| 4 | Industrials | 4.57% |
| 5 | Materials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CVS Health
CVS
$137B
| $21.3M | 11.13% |
217,931
+12
| +0% | +$1.18K |
|
|
2
Cardinal Health
CAH
$53.5B
| $20.1M | 10.5% |
225,205
+44,987
| +25% | +$3.82M |
|
3
Zevra Therapeutics
ZVRA
$755M
| $15.9M | 8.31% |
50,079
+11,023
| +28% | +$2.99M |
|
|
NEOS
4
DELISTED
Neos Therapeutics, Inc
NEOS
| $13.1M | 6.84% |
938,598
+31,240
| +3% | +$471K |
|
|
FOMX
5
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $11.4M | 5.97% |
1,408,597
+408,597
| +41% | +$3.05M |
|
|
6
PRA Group
PRAA
$691M
| $9.44M | 4.93% |
272,000
+182,000
| +202% | +$8.14M |
|
|
BERY
7
DELISTED
Berry Global Group, Inc.
BERY
| $8.68M | 4.53% |
261,171
+16,335
| +7% | +$518K |
|
|
SWFT
8
DELISTED
Swift Transportation Company
SWFT
| $8.02M | 4.19% |
580,000
+330,000
| +132% | +$5.03M |
|
9
HCA Healthcare
HCA
$82.3B
| $7.18M | 3.75% |
106,232
+30,358
| +40% | +$2.12M |
|
|
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.84M | 3.57% |
465,000
+210,495
| +83% | +$3.1M |
|
11
Elevance Health
ELV
$80.9B
| $6.28M | 3.28% |
45,000
-118
| -0.3% | -$16.3K |
|
|
PFNX
12
DELISTED
Pfenex Inc.
PFNX
| $6M | 3.13% |
484,809
+83,908
| +21% | +$1.24M |
|
13
Goldman Sachs
GS
$314B
| $5.46M | 2.85% |
30,282
+10,050
| +50% | +$1.87M |
|
|
14
Biogen
BIIB
$30.4B
| $4.32M | 2.26% |
+14,111
| New | +$4.05M |
|
|
PARA
15
DELISTED
Paramount Global Class B
PARA
| $4.01M | 2.09% |
+85,000
| New | +$3.99M |
|
|
DVAX
16
DELISTED
Dynavax Technologies
DVAX
| $3.75M | 1.96% |
155,000
| – | – |
|
17
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $3.38M | 1.77% |
1,300,000
-1,700,000
| -57% | -$349M |
|
|
TWX
18
DELISTED
Time Warner Inc
TWX
| $3.26M | 1.7% |
+50,443
| New | +$3.53M |
|
19
Sunoco
SUN
$13.9B
| $2.97M | 1.55% |
75,000
| – | – |
|
20
Microsoft
MSFT
$2.93T
| $2.58M | 1.35% |
46,488
+8,290
| +22% | +$436K |
|
21
Amgen
AMGN
$198B
| $2.5M | 1.3% |
15,377
+56
| +0.4% | +$8.8K |
|
|
AXDX
22
DELISTED
Accelerate Diagnostics
AXDX
| $2.45M | 1.28% |
11,386
+1,886
| +20% | +$344K |
|
23
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.32M | 1.21% |
65,000
-25,000
| -28% | -$881K |
|
24
Citigroup
C
$217B
| $1.91M | 1% |
36,966
+349
| +1% | +$18.5K |
|
25
Alphabet (Google) Class C
GOOG
$4.22T
| $1.61M | 0.84% |
42,520
-14,000
| -25% | -$502K |
|
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q4 2015 Portfolio in Review
As of Q4 2015, DSC Advisors held 82 positions worth $191M, down 7.1% from $206M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
DSC Advisors withdrew a net $345M in Q4 2015, closing 23 positions and reducing 10 holdings. Its most notable exit was FedEx, an estimated $7.22M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 56% a quarter earlier, followed by Financials and Communication Services.
Against the trend, DSC Advisors opened a new position in Biogen worth $4.32M.
- DSC Advisors's largest Q4 2015 buy was Biogen: 14,111 shares worth $4.32M.
- DSC Advisors added most to PRA Group in Q4 2015, an estimated $8.14M increase.
- DSC Advisors's biggest Q4 2015 reduction was RoadRunner Transportation Systems, Inc., cutting an estimated $8.4M.
- DSC Advisors fully exited FedEx in Q4 2015, selling an estimated $7.22M.
- DSC Advisors's ten largest holdings make up 64% of its $191M portfolio in Q4 2015.
- DSC Advisors opened 18 new positions and closed 23 in Q4 2015.
- DSC Advisors's portfolio value fell 7.1% quarter-over-quarter to $191M.
Based on DSC Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.